Reviewed by Brunilda Nazario on December 03, 2019
Mayo Clinic: “Type 2 Diabetes.”<br> Pharmacy and Therapeutics: “Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in the Management of Diabetes.”<br> FDA: “Information on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors,” “Glumetza TM, 500 mg (metformin hydrochloride extended release tablets) tablet, film coated, extended release.”<br> FDA: “Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors.”
© 2019 WebMD, LLC. All rights reserved.
Your doctor may suggest these treatments to control blood sugar before turning to insulin.
Find WebMD on:
©2005-2019 WebMD LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.